Avicenna Journal of Clinical Microbiology and Infection

Published by: Kowsar

Inside Helicobacter pylori: A Serious Threat to Humans

Abdul Rehman 1 , *
Author Information
1 Department of Microbiology and Molecular Genetics, University of the Punjab, Quaid-e-Azam Campus, Lahore, Pakistan
Article information
  • Avicenna Journal of Clinical Microbiology and Infection: February 2018, 5 (1); e60463
  • Published Online: January 8, 2018
  • Article Type: Review Article
  • Received: August 29, 2017
  • Revised: October 11, 2017
  • Accepted: December 21, 2017
  • DOI: 10.5812/ajcmi.60463

To Cite: Rehman A. Inside Helicobacter pylori: A Serious Threat to Humans, Avicenna J Clin Microb Infec. 2018 ;5(1):e60463. doi: 10.5812/ajcmi.60463.

Abstract
Copyright: Copyright © 2018, Avicenna Journal of Clinical Microbiology and Infection. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Discussion and Conclusion
Acknowledgements
Footnote
References
  • 1. Garcia A, Salas-Jara MJ, Herrera C, Gonzalez C. Biofilm and Helicobacter pylori: from environment to human host. World J Gastroenterol. 2014;20(19):5632-8. doi: 10.3748/wjg.v20.i19.5632. [PubMed: 24914322].
  • 2. Wroblewski LE, Peek RJ, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev. 2010;23(4):713-39. doi: 10.1128/CMR.00011-10. [PubMed: 20930071].
  • 3. Megraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev. 2007;20(2):280-322. doi: 10.1128/CMR.00033-06. [PubMed: 17428887].
  • 4. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002;347(15):1175-86. doi: 10.1056/NEJMra020542. [PubMed: 12374879].
  • 5. Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori. Clin Microbiol Rev. 1997;10(4):720-41. [PubMed: 9336670].
  • 6. Malaty HM. Epidemiology of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol. 2007;21(2):205-14. doi: 10.1016/j.bpg.2006.10.005. [PubMed: 17382273].
  • 7. Bruce MG, Maaroos HI. Epidemiology of helicobacter pylori infection. Helicobacter. 2008;13 Suppl 1:1-6. doi: 10.1111/j.1523-5378.2008.00631.x. [PubMed: 18783514].
  • 8. Eusebi LH, Zagari RM, Bazzoli F. Epidemiology of helicobacter pylori infection. Helicobacter. 2014;19 Suppl 1:1-5. doi: 10.1111/hel.12165. [PubMed: 25167938].
  • 9. Conteduca V, Sansonno D, Lauletta G, Russi S, Ingravallo G, Dammacco F. H. pylori infection and gastric cancer: state of the art (review). Int J Oncol. 2013;42(1):5-18. doi: 10.3892/ijo.2012.1701. [PubMed: 23165522].
  • 10. van Blankenstein M, van Vuuren AJ, Looman CW, Ouwendijk M, Kuipers EJ. The prevalence of Helicobacter pylori infection in the Netherlands. Scand J Gastroenterol. 2013;48(7):794-800. doi: 10.3109/00365521.2013.799221. [PubMed: 23795659].
  • 11. Bastos J, Peleteiro B, Barros R, Alves L, Severo M, de Fatima Pina M, et al. Sociodemographic determinants of prevalence and incidence of Helicobacter pylori infection in Portuguese adults. Helicobacter. 2013;18(6):413-22. doi: 10.1111/hel.12061. [PubMed: 23725608].
  • 12. Kim N. Prevalence and transmission routes of H. pylori. Helicobacter pylori. 2016:3-19. doi: 10.1007/978-981-287-706-2_1.
  • 13. Ozaydin N, Turkyilmaz SA, Cali S. Prevalence and risk factors of Helicobacter pylori in Turkey: a nationally-representative, cross-sectional, screening with the (1)(3)C-Urea breath test. BMC Public Health. 2013;13:1215. doi: 10.1186/1471-2458-13-1215. [PubMed: 24359515].
  • 14. Sethi A, Chaudhuri M, Kelly L, Hopman W. Prevalence of Helicobacter pylori in a First Nations population in northwestern Ontario. Can Fam Physician. 2013;59(4):182-7. [PubMed: 23585621].
  • 15. Alvarado-Esquivel C. Seroepidemiology of helicobacter pylori infection in pregnant women in rural durango, Mexico. Int J Biomed Sci. 2013;9(4):224-9. [PubMed: 24711758].
  • 16. Hanafi MI, Mohamed AM. Helicobacter pylori infection: seroprevalence and predictors among healthy individuals in Al Madinah, Saudi Arabia. J Egypt Public Health Assoc. 2013;88(1):40-5. doi: 10.1097/01.EPX.0000427043.99834.a4. [PubMed: 23528531].
  • 17. Lim SH, Kwon JW, Kim N, Kim GH, Kang JM, Park MJ, et al. Prevalence and risk factors of Helicobacter pylori infection in Korea: nationwide multicenter study over 13 years. BMC Gastroenterol. 2013;13:104. doi: 10.1186/1471-230X-13-104. [PubMed: 23800201].
  • 18. Sodhi JS, Javid G, Zargar SA, Tufail S, Shah A, Khan BA, et al. Prevalence of Helicobacter pylori infection and the effect of its eradication on symptoms of functional dyspepsia in Kashmir, India. J Gastroenterol Hepatol. 2013;28(5):808-13. doi: 10.1111/jgh.12178. [PubMed: 23432600].
  • 19. Xie C, Lu NH. Review: clinical management of Helicobacter pylori infection in China. Helicobacter. 2015;20(1):1-10. doi: 10.1111/hel.12178. [PubMed: 25382801].
  • 20. Vilaichone RK, Mahachai V, Shiota S, Uchida T, Ratanachu-ek T, Tshering L, et al. Extremely high prevalence of Helicobacter pylori infection in Bhutan. World J Gastroenterol. 2013;19(18):2806-10. doi: 10.3748/wjg.v19.i18.2806. [PubMed: 23687418].
  • 21. Mathewos B, Moges B, Dagnew M. Seroprevalence and trend of Helicobacter pylori infection in Gondar University Hospital among dyspeptic patients, Gondar, North West Ethiopia. BMC Res Notes. 2013;6:346. doi: 10.1186/1756-0500-6-346. [PubMed: 24229376].
  • 22. Benajah DA, Lahbabi M, Alaoui S, El Rhazi K, El Abkari M, Nejjari C, et al. Prevalence of Helicobacter pylori and its recurrence after successful eradication in a developing nation (Morocco). Clin Res Hepatol Gastroenterol. 2013;37(5):519-26. doi: 10.1016/j.clinre.2013.02.003. [PubMed: 23567104].
  • 23. Olokoba AB, Gashau W, Bwala S, Adamu A, Salawu FK. Helicobacter pylori infection in Nigerians with dyspepsia. Ghana Med J. 2013;47(2):79-81. [PubMed: 23966744].
  • 24. Fernandez-Gonzalez E, Backert S. DNA transfer in the gastric pathogen Helicobacter pylori. J Gastroenterol. 2014;49(4):594-604. doi: 10.1007/s00535-014-0938-y. [PubMed: 24515309].
  • 25. Xue LJ, Su QS, Mao XB, Liu XB, Lin Q, Liu C, et al. A double edged sword, Roles of helicobacter pylori in gastric carcinoma. Gastric carcinoma, molecular aspects and current advances. Croatia, European Union: INTECH Open Access Publisher; 2011. doi: 10.5772/16691.
  • 26. Martin C, Low WL, Gupta A, Amin MC, Radecka I, Britland ST, et al. Strategies for antimicrobial drug delivery to biofilm. Curr Pharm Des. 2015;21(1):43-66. [PubMed: 25189862].
  • 27. Stark RM, Gerwig GJ, Pitman RS, Potts LF, Williams NA, Greenman J, et al. Biofilm formation by Helicobacter pylori. Lett Appl Microbiol. 1999;28(2):121-6. [PubMed: 10063642].
  • 28. Adekoya KO, Ahmed RA, Oboh BO, Alimba CG. Relationships between dermatoglyphics and multiple intelligence among selected secondary school students in lagos state, Nigeria. Nigerian Soc Exp Biol. 2013;13(3):53-60.
  • 29. Cellini L. Helicobacter pylori: a chameleon-like approach to life. World J Gastroenterol. 2014;20(19):5575-82. doi: 10.3748/wjg.v20.i19.5575. [PubMed: 24914317].
  • 30. Garza-Gonzalez E, Perez-Perez GI, Maldonado-Garza HJ, Bosques-Padilla FJ. A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication. World J Gastroenterol. 2014;20(6):1438-49. doi: 10.3748/wjg.v20.i6.1438. [PubMed: 24587620].
  • 31. Ma HJ, Wang JL. Quadruple therapy for eradication of Helicobacter pylori. World J Gastroenterol. 2013;19(6):931-5. doi: 10.3748/wjg.v19.i6.931. [PubMed: 23429422].
  • 32. Bang CS, Baik GH. Attempts to enhance the eradication rate of Helicobacter pylori infection. World J Gastroenterol. 2014;20(18):5252-62. doi: 10.3748/wjg.v20.i18.5252. [PubMed: 24833855].
  • 33. Takeuchi H, Trang VT, Morimoto N, Nishida Y, Matsumura Y, Sugiura T. Natural products and food components with anti-Helicobacter pylori activities. World J Gastroenterol. 2014;20(27):8971-8. doi: 10.3748/wjg.v20.i27.8971. [PubMed: 25083070].
  • 34. Vale FF, Roxo Rosa M, Oleastro M. Helicobacter pylori resistance to antibiotics. In: Mendez Vilas A, editor. Science against microbial pathogens: communicating current research and technological advances. Spain: FORMATEX; 2011. p. 745-56.
  • 35. Smith SM, O'Morain C, McNamara D. Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance. World J Gastroenterol. 2014;20(29):9912-21. doi: 10.3748/wjg.v20.i29.9912. [PubMed: 25110421].
  • 36. Wu W, Yang Y, Sun G. Recent insights into antibiotic resistance inhelicobacter pylori eradication. Gastroenterol Res Pract. 2012;2012:1-8. doi: 10.1155/2012/723183.
  • 37. Amaro HM, Barros R, Guedes AC, Sousa-Pinto I, Malcata FX. Microalgal compounds modulate carcinogenesis in the gastrointestinal tract. Trends Biotechnol. 2013;31(2):92-8. doi: 10.1016/j.tibtech.2012.11.004. [PubMed: 23260440].
  • 38. Amin M, Anwar F, Naz F, Mehmood T, Saari N. Anti-Helicobacter pylori and urease inhibition activities of some traditional medicinal plants. Molecules. 2013;18(2):2135-49. doi: 10.3390/molecules18022135. [PubMed: 23434867].
  • 39. Vale FF, Oleastro M. Overview of the phytomedicine approaches against Helicobacter pylori. World J Gastroenterol. 2014;20(19):5594-609. doi: 10.3748/wjg.v20.i19.5594. [PubMed: 24914319].
  • 40. Aydin A, Ersoz G, Tekesin O, Akcicek E, Tuncyurek M. Garlic oil and Helicobacter pylori infection. Am J Gastroenterol. 2000;95(2):563-4. doi: 10.1111/j.1572-0241.2000.t01-1-01812.x. [PubMed: 10685782].
  • 41. Graham DY, Anderson SY, Lang T. Garlic or jalapeno peppers for treatment of Helicobacter pylori infection. Am J Gastroenterol. 1999;94(5):1200-2. doi: 10.1111/j.1572-0241.1999.01066.x. [PubMed: 10235193].
  • 42. Nir Y, Potasman I, Stermer E, Tabak M, Neeman I. Controlled trial of the effect of cinnamon extract on Helicobacter pylori. Helicobacter. 2000;5(2):94-7. [PubMed: 10849058].
  • 43. Salem EM, Yar T, Bamosa AO, Al-Quorain A, Yasawy MI, Alsulaiman RM, et al. Comparative study of Nigella Sativa and triple therapy in eradication of Helicobacter Pylori in patients with non-ulcer dyspepsia. Saudi J Gastroenterol. 2010;16(3):207-14. doi: 10.4103/1319-3767.65201. [PubMed: 20616418].
  • 44. Coelho LG, Bastos EM, Resende CC, Paula e Silva CM, Sanches BS, de Castro FJ, et al. Brazilian green propolis on Helicobacter pylori infection. a pilot clinical study. Helicobacter. 2007;12(5):572-4. doi: 10.1111/j.1523-5378.2007.00525.x. [PubMed: 17760728].
  • 45. Beil W, Kilian P. EPs 7630, an extract from Pelargonium sidoides roots inhibits adherence of Helicobacter pylori to gastric epithelial cells. Phytomedicine. 2007;14 Suppl 6:5-8. doi: 10.1016/j.phymed.2006.11.024. [PubMed: 17188478].
  • 46. Wittschier N, Faller G, Hensel A. An extract of Pelargonium sidoides (EPs 7630) inhibits in situ adhesion of Helicobacter pylori to human stomach. Phytomedicine. 2007;14(4):285-8. doi: 10.1016/j.phymed.2006.12.008. [PubMed: 17350240].
  • 47. Burger O, Ofek I, Tabak M, Weiss EI, Sharon N, Neeman I. A high molecular mass constituent of cranberry juice inhibits helicobacter pylori adhesion to human gastric mucus. FEMS Immunol Med Microbiol. 2000;29(4):295-301. [PubMed: 11118911].
  • 48. Bodet C, Grenier D, Chandad F, Ofek I, Steinberg D, Weiss EI. Potential oral health benefits of cranberry. Crit Rev Food Sci Nutr. 2008;48(7):672-80. doi: 10.1080/10408390701636211. [PubMed: 18663617].
  • 49. Wang YC. Medicinal plant activity on Helicobacter pylori related diseases. World J Gastroenterol. 2014;20(30):10368-82. doi: 10.3748/wjg.v20.i30.10368. [PubMed: 25132753].
  • 50. Shi DH, Liu YW, Liu WW, Gu ZF. Inhibition of urease by extracts derived from 15 Chinese medicinal herbs. Pharm Biol. 2011;49(7):752-5. doi: 10.3109/13880209.2010.547205. [PubMed: 21639688].
  • 51. Hassani AR, Ordouzadeh N, Ghaemi A, Amirmozafari N, Hamdi K, Nazari R. In vitro inhibition of Helicobacter pylori urease with non and semi fermented Camellia sinensis. Indian J Med Microbiol. 2009;27(1):30-4. [PubMed: 19172056].
  • 52. Pastene E, Speisky H, Garcia A, Moreno J, Troncoso M, Figueroa G. In vitro and in vivo effects of apple peel polyphenols against Helicobacter pylori. J Agric Food Chem. 2010;58(12):7172-9. doi: 10.1021/jf100274g. [PubMed: 20486708].
  • 53. Pastene E, Troncoso M, Figueroa G, Alarcon J, Speisky H. Association between polymerization degree of apple peel polyphenols and inhibition of Helicobacter pylori urease. J Agric Food Chem. 2009;57(2):416-24. doi: 10.1021/jf8025698. [PubMed: 19128009].
  • 54. Chen Y, Liao J, Chen M, Huang Q,, Lu Q. Gossypol, new class of urease inhibitors, molecular docking and inhibition assay. J Chem Pharm Res. 2015;7(1):10-5.
  • 55. Yu XD, Xie JH, Wang YH, Li YC, Mo ZZ, Zheng YF, et al. Selective antibacterial activity of patchouli alcohol against helicobacter pylori based on inhibition of urease. Phytother Res. 2015;29(1):67-72. doi: 10.1002/ptr.5227. [PubMed: 25243578].
  • 56. Yu XD, Zheng RB, Xie JH, Su JY, Huang XQ, Wang YH, et al. Biological evaluation and molecular docking of baicalin and scutellarin as Helicobacter pylori urease inhibitors. J Ethnopharmacol. 2015;162:69-78. doi: 10.1016/j.jep.2014.12.041. [PubMed: 25557028].
  • 57. Zambelli B, Berardi A, Martin-Diaconescu V, Mazzei L, Musiani F, Maroney MJ, et al. Nickel binding properties of Helicobacter pylori UreF, an accessory protein in the nickel-based activation of urease. J Biol Inorg Chem. 2014;19(3):319-34. doi: 10.1007/s00775-013-1068-3. [PubMed: 24292245].
  • 58. Xiao ZP, Wang XD, Peng ZY, Huang S, Yang P, Li QS, et al. Molecular docking, kinetics study, and structure-activity relationship analysis of quercetin and its analogous as Helicobacter pylori urease inhibitors. J Agric Food Chem. 2012;60(42):10572-7. doi: 10.1021/jf303393n. [PubMed: 23067328].
  • 59. Saeed A, Khan MS, Rafique H, Shahid M, Iqbal J. Design, synthesis, molecular docking studies and in vitro screening of ethyl 4-(3-benzoylthioureido) benzoates as urease inhibitors. Bioorg Chem. 2014;52:1-7. doi: 10.1016/j.bioorg.2013.10.001. [PubMed: 24269986].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .